Adam

Beware of falsified medicines from unregistered websites

EMA is urging the general public not to buy medicines from unauthorised websites and other vendors aiming to exploit fears and concerns during the ongoing pandemic of coronavirus disease (COVID-19). Vendors may claim that their products can treat or prevent COVID-19 or may appear to provide easy access to legitimate medicines that are otherwise not […]

Coordinated central bank action to further enhance the provision of US dollar liquidity

ECB and other major central banks to offer 7-day US dollar operations on a daily basis Operations with 84-day maturity continue to be offered weekly New frequency effective as of 23 March 2020, to remain in place for as long as appropriate to support smooth functioning of US dollar funding markets The Bank of Canada, […]

Guidance to sponsors on how to manage clinical trials during the COVID-19 pandemic

The European Commission, the European Medicines Agency (EMA) and national Head of Medicines Agencies (HMA) have published new recommendations for sponsors on how to manage the conduct of clinical trials in the context of the coronavirus disease (COVID-19) pandemic. The impact of the pandemic on European health systems and more broadly on society, will make […]

EIB Group will rapidly mobilise up to EUR 40 billion to fight crisis caused by Covid-19

EIB Group offers support to European companies under strain from the coronavirus pandemic and its economic effects Potential financing of up to EUR 40 billion can be mobilised at short notice, backed up by guarantees from the European Investment Bank Group and the European Union budget Extra funding available for healthcare sector for emergency infrastructure […]

Call to pool research resources into large multi-centre, multi-arm clinical trials to generate sound evidence on COVID-19 treatments

EMA’s Human Medicines Committee (CHMP) has published a statement urging the EU research community to prioritise large randomised controlled studies because they are most likely to generate the conclusive evidence needed to enable rapid development and approval of potential treatments of COVID-19. The statement promotes a harmonised approach to data collection and a robust methodology […]

Judgment in Joined Cases Sánchez Ruiz and Fernández Álvarez and Others v Comunidad de Madrid

In the judgment Sánchez Ruiz et Fernández Álvarez and Others (Joined Cases C-103/18 and C-429/18), delivered on 19 March 2020, the Court ruled that the Member States and/or social partners cannot exclude from the concept of ‘successive fixed-term employment contracts or relationships’, provided for in Clause 5 of the Framework Agreement on fixed-term work (‘the […]

EU law does not preclude Member States from providing for civil proceedings for confiscation which are unrelated to a finding of a criminal offence

BP, the Chair of the supervisory board of a Bulgarian bank was subject to criminal proceedings for having incited others, from December 2011 to 19 June 2014, to misappropriate funds belonging to that bank in the sum of approximately €105 million. The criminal proceedings are pending and have not yet given rise to a final […]

First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development

The first global regulatory workshop on COVID-19, was convened under the umbrella of the International Coalition of Medicines Regulatory Authorities (ICMRA). The virtual meeting brought together delegates from 17 different countries, representing more than 20 medicines regulatory authorities globally, as well as experts from the World Health Organization and the European Commission, to discuss the […]